Variant report
Variant | esv3510219 |
---|---|
Chromosome Location | chr13:48072807-48073293 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs201180393 | chr13:48072890-48072891 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs77481982 | chr13:48072892-48072893 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs12867526 | chr13:48072893-48072894 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs369505030 | chr13:48072894-48072895 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs372581188 | chr13:48072895-48072896 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs572681803 | chr13:48072896-48072897 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs529677952 | chr13:48072908-48072909 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs541735026 | chr13:48072929-48072930 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs186208918 | chr13:48072931-48072932 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs563396140 | chr13:48072938-48072939 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs190667395 | chr13:48072948-48072949 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs375629028 | chr13:48073006-48073007 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs376353189 | chr13:48073066-48073067 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs181552254 | chr13:48073113-48073114 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs570678151 | chr13:48073129-48073130 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs534838943 | chr13:48073133-48073134 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs55857069 | chr13:48073141-48073142 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs568375388 | chr13:48073149-48073150 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs376338664 | chr13:48073159-48073160 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs375449494 | chr13:48073204-48073205 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs536603948 | chr13:48073205-48073206 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs61951796 | chr13:48073214-48073215 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs114065324 | chr13:48073257-48073258 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs77526488 | chr13:48073259-48073260 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17899364 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Trisomy | 24170809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Alveolar rhabdomyosarcoma | 16790082 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 18632612 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 19242612 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 17245344 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Developmental delay | 21147756 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Melanoma | 18172304 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Chronic lymphocytic leukemia | 17805327 | CNVD |
Mental retardation | 17502991 | CNVD |
Retinoblastoma | 17502991 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Liposarcoma | 21253554 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Cervical cancer | 21062161 | CNVD |
microdeletion syndrome | 19284877 | CNVD |
Ovarian cancer | 22355333 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Multiple myeloma | 19135901 | CNVD |
Autism | 18414403 | CNVD |
Neurocytoma | 17123091 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Prostate cancer | 16461572 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Prostate cancer | 21088497 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Breast cancer | 22048815 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Chronic lymphocytic leukemia | 21049055 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Cancer | 20164920 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Breast cancer | 21858162 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Osteosarcoma | 21215367 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:48071200-48075200 | Enhancers | Primary monocytes fromperipheralblood | blood |
2 | chr13:48071600-48073400 | Enhancers | Hela-S3 | cervix |
3 | chr13:48071800-48073600 | Enhancers | Primary hematopoietic stem cells | blood |
4 | chr13:48071800-48073600 | Weak transcription | Brain Hippocampus Middle | brain |
5 | chr13:48072000-48073800 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
6 | chr13:48072200-48076400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr13:48072400-48073000 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
8 | chr13:48072400-48073400 | Enhancers | Muscle Satellite Cultured Cells | -- |
9 | chr13:48072600-48074400 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
10 | chr13:48072600-48076200 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
11 | chr13:48072600-48076200 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
12 | chr13:48072800-48073400 | Enhancers | Monocytes-CD14+_RO01746 | blood |
13 | chr13:48072800-48073600 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
14 | chr13:48072800-48082600 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
15 | chr13:48073000-48073400 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
16 | chr13:48073200-48073400 | Enhancers | NH-A | brain |
17 | chr13:48073200-48073600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
18 | chr13:48073200-48073600 | Enhancers | HMEC | breast |
19 | chr13:48073200-48074800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |